Skip to main content

Table 1 Clinical and molecular data of 20 LOPD patients

From: Decreased outlet angle of the superior cerebellar artery as indicator for dolichoectasia in late onset Pompe disease

Pat.-Nr.

Sex

GAA-Genotype

Age [years]

Duration disease (years)

Duration ERT (month)

Cardio-vascular risk factors

P1a

F

IVS1 (− 13 T > G)

IVS9 G > C)

26

15

67

HL

P2

F

p.L552P

p.P493L

37

10

33

HL, O

P3a

M

IVS1 (−13 T > G)

c.2136-7delGT

50

40

116

HYP, HL

P4a

M

IVS1 (−13 T > G)

p.W499R

50

18

130

DM, HL

P5a

M

IVS1 (−13 T > G)

p.P493L

52

15

63

HYP, HL

P6a

F

IVS1 (−13 T > G)

p.L552P

53

17

99

HYP, HL, O, S

P7a

M

IVS1 (−13 T > G)

p.C103G

59

14

135

HYP, DM, HL, O

P8a

F

IVS1 (−13 T > G)

p.P493L

61

21

63

HYP, HL

P9

M

IVS1 (−13 T > G)

p.G309R

64

11

14

HYP, DM, O

P10a

F

IVS1 (−13 T > G)

del exon 18

75

40

103

HYP

P11

M

IVS1 (−13 T > G)

c.832delC

45

6

17

HYP, HL

P12

F

IVS1 (−13 T > G)

c.525delT

66

7

33

HYP, HL

P13

M

IVS1 (−13 T > G)

IVS1 (−13 T > G)

61

13

29

HYP, HL

P14

F

IVS1 (−13 T > G)

c.2481 + 102_2646 + 31del

54

18

44

HYP, HL

P15

F

IVS1 (−13 T > G)

c.2481 + 102_2646 + 31del

56

19

48

HYP, HL

P16a

F

IVS1 (−13 T > G)

c307 T > G

49

23

119

HL

P17

M

IVS1 (−13 T > G)

p.G309R

81

6

37

HYP, HL

P18

M

IVS1 (−13 T > G)

c.794delG

49

13

84

NONE

P19

F

IVS1 (−13 T > G)

c.925G > A

61

2

9

HYP

P20

M

IVS1 (−13 T > G)

c.525delT

19

19

132

NONE

  1. Patient P1-P10 were numbered according to their number in the previous study by Hensel et al. [7]. P5 + P8 and P14 + 15 were siblings; a patients with 5 years follow-up; Abbr.: ERT enzyme replacement therapy, GAA Glucosidase alpha gene. Risk factors: DM diabetes mellitus, HL hyperlipidemia, HYP Hypertension, O obesity, S smoking